26 related articles for article (PubMed ID: 31957819)
1. Ovarian cancer classification and prognosis assessment model based on prognostic target genes in key microRNA-target gene networks.
Chen X; Li Y; He J
J Gene Med; 2024 Jan; 26(1):e3575. PubMed ID: 37548130
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.
Yang L; Ma HL
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1062-1071. PubMed ID: 32096176
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Impairment in Multiple Sclerosis.
Maiese K
Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508898
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the mechanism of miR-122-5p in mediating FOXO3 injury and apoptosis of mouse cochlear hair cells induced by hydrogen peroxide.
Chen J; Qin J; Liu J
Exp Ther Med; 2022 Jun; 23(6):435. PubMed ID: 35607378
[TBL] [Abstract][Full Text] [Related]
5. Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.
Jia Y; Li J; Wang J; Luo T; Jing X; Zhao H
Anal Cell Pathol (Amst); 2022; 2022():1732365. PubMed ID: 35602576
[TBL] [Abstract][Full Text] [Related]
6. RP5-1148A21.3 (lncRP5) exerts oncogenic function in human ovarian carcinoma.
Sun P; Bao A; Hua X; Cao J; Ding Y
Acta Biochim Biophys Sin (Shanghai); 2022 Feb; 54(2):209-219. PubMed ID: 35538027
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K.
Geng L; Wang Z; Tian Y
J Ovarian Res; 2022 Jan; 15(1):1. PubMed ID: 34980214
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis.
Zhao H; Chen W; Zhu Y; Lou J
J Gastrointest Oncol; 2021 Aug; 12(4):1691-1703. PubMed ID: 34532120
[TBL] [Abstract][Full Text] [Related]
9. MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway.
Zhang L; Tong Z; Sun Z; Zhu G; Shen E; Huang Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32985648
[TBL] [Abstract][Full Text] [Related]
10. Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.
Maiese K
Neural Regen Res; 2021 Mar; 16(3):448-455. PubMed ID: 32985464
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MIF-AS1 aggravates the progression of ovarian cancer by sponging miRNA-31-5p.
Fan Y; Wang L; Han XC; Ma HY; Zhang N; Zhe L
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2248-2255. PubMed ID: 32196575
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
Pei CL; Fei KL; Yuan XY; Gong XJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
[TBL] [Abstract][Full Text] [Related]
13. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.
Kandettu A; Adiga D; Devi V; Suresh PS; Chakrabarty S; Radhakrishnan R; Kabekkodu SP
Genes Dis; 2022 Nov; 9(6):1443-1465. PubMed ID: 36157483
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.
Yang N; Zhang Q; Bi XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):65-73. PubMed ID: 31957819
[TBL] [Abstract][Full Text] [Related]
15. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
